Ascend Capital’s Abbott ABT Stock Holding History

Ascend Capital’s Portfolio ABT Stock Details ABT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-87,373	Closed	-$5.33M	–	166
2018 Q2	$5.33M	Sell	87,373 -38,959	-31%	-$2.36M	0.25%	104
2018 Q1	$7.57M	Buy	+126,332	New	+$7.61M	0.31%	104
2017 Q1	–	Sell	-108,910	Closed	-$4.18M	–	139
2016 Q4	$4.18M	Buy	+108,910	New	+$4.32M	0.21%	108

Other funds holding ABT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Ascend Capital's ABT Position: Q3 2018 in Review

Ascend Capital sold out of Abbott (ABT) in Q3 2018, closing a stake of 87,373 shares — an estimated $5.33M sold.

Ascend Capital first reported a position in ABT in Q4 2016 and held it in 3 quarters. The position peaked at $7.57M in Q1 2018. 1,869 funds tracked by Wall St. Rank hold ABT as of Q3 2018.

Ascend Capital reported no remaining Abbott position as of Q3 2018 after selling out during the quarter.
Ascend Capital sold 87,373 Abbott shares in Q3 2018, an estimated $5.33M.
Ascend Capital first reported a position in Abbott in Q4 2016 and held it in 3 quarters.
Ascend Capital's Abbott position peaked at $7.57M in Q1 2018.
1,869 funds tracked by Wall St. Rank held Abbott as of Q3 2018.

Based on Ascend Capital's 13F filing for Q3 2018, filed 13 Nov 2018.